Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT06493279 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06493279
- Sponsor
- RJK Biopharma Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2026-11-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.